Compound Detail
CHEMBL4594250
NETARSUDIL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Cc1ccc(C(=O)OCc2ccc([C@@H](CN)C(=O)Nc3ccc4cnccc4c3)cc2)c(C)c1
Basic Information
| ChEMBL ID | CHEMBL4594250 |
| Name | NETARSUDIL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | OURRXQUGYQRVML-AREMUKBSSA-N |
| Therapeutic | ✓ Yes |
| Active Moiety | CHEMBL4753043 |
3
Targets
34
Activities
2
Assay Types
5
PK Parameters
16
Publications
3
Known Names
5
Indications
Molecular Properties
453.5
MW (Da)
4.89
ALogP
5
HBA
2
HBD
94.3
PSA (Ų)
0.39
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2017 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Fuchs' Endothelial Dystrophy Fuchs' Endothelial Dystrophy Glaucoma Corneal Edema Glaucoma, Open-Angle
ATC Classification
S01EX05
netarsudil
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Activity Summary
IC50 26 meas. best 8.26
Ki 8 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Rho-associated protein kinase 2 CHEMBL2973 | Ki | 9.0 | 8.816 | 1.0 | 5 |
| Rho-associated protein kinase 1 CHEMBL3231 | Ki | 9.0 | 9.0 | 1.0 | 3 |
| Rho-associated protein kinase 1 CHEMBL3231 | IC50 | 8.26 | 7.6668 | 5.5 | 19 |
| Rho-associated protein kinase 2 CHEMBL2973 | IC50 | 8.1 | 7.922 | 8.0 | 5 |
| Unchecked CHEMBL612545 | IC50 | 7.8 | 7.45 | 16.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 2.6 | hr | Sus scrofa |
| T1/2 | 2.917 | hr | Homo sapiens |
| T1/2 | 2.333 | hr | Oryctolagus cuniculus |
| T1/2 | 1.633 | hr | Canis lupus familiaris |
| T1/2 | 1.817 | hr | Macaca fascicularis |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine